2021
DOI: 10.1620/tjem.253.275
|View full text |Cite
|
Sign up to set email alerts
|

Unsatisfactory Short-Term Neurodevelopmental Outcomes of Preterm Infants Who Received Polymyxin B-Immobilized Fiber Column-Direct Hemoperfusion for Septic Shock

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…Since 2011, a PMX-DHP column specialized for neonates with a priming volume of only 8 mL (Toraymyxin® 01-R; Toray Medical Co., Tokyo, Japan) has been available in Japanese clinical settings. We have been using PMX-DHP for neonatal septic shock and have published several of our experiences [2-6]. Similar to the successful experience described by Mitaka et al [1] , we use PMX-DHP as long as possible, instead of the conventional duration (2 h per session [7]) when there are no adverse events and extracorporeal circulation is possible.…”
mentioning
confidence: 94%
“…Since 2011, a PMX-DHP column specialized for neonates with a priming volume of only 8 mL (Toraymyxin® 01-R; Toray Medical Co., Tokyo, Japan) has been available in Japanese clinical settings. We have been using PMX-DHP for neonatal septic shock and have published several of our experiences [2-6]. Similar to the successful experience described by Mitaka et al [1] , we use PMX-DHP as long as possible, instead of the conventional duration (2 h per session [7]) when there are no adverse events and extracorporeal circulation is possible.…”
mentioning
confidence: 94%